Simply and effectively distribute safety reports to clinical investigators across all studies and programs utilizing a specific investigational drug.
Effective and Compliant Safety Report Distribution
Mobile-optimized, Part 11-compliant eSignatures
Each investigator can confirm receipt on their mobile, desktop, or tablet using their 21 CFR Part 11 eSignature.
Shared signatures across multiple studies
Submissions and signatures are shared across all relevant studies, requiring only one report submission for a multi-study program, and one signature from the investigator.
Audit trail and real-time reports
Signatures are time and date stamped to ensure a full audit trail and sponsors can run real-time reports showing the status and response rate. The Longboat Platform’s virtual dashboards allow sponsors to quickly drill down to regions and sites where there has not yet been a response.
Intuitive, familiar interface
Sites and sponsors already working within the Longboat Platform can action their reports in a familiar environment already used for multiple study tasks like training, visit implementation, pre-screening, and more.
Distribute reports worldwide
Deployed in over 60 countries, Longboat’s safety reporting provides a global solution to deployment, tracking, and reporting of safety reports.